WT Asset Management Ltd Takes $86.32 Million Position in Astera Labs, Inc. $ALAB

WT Asset Management Ltd acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 178,711 shares of the company’s stock, valued at approximately $86,321,000. Astera Labs makes up approximately 1.7% of WT Asset Management Ltd’s investment portfolio, making the stock its 15th largest position. WT Asset Management Ltd owned about 0.10% of Astera Labs as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of ALAB. Bell Investment Advisors Inc acquired a new stake in Astera Labs during the 2nd quarter valued at $43,000. Reflection Asset Management purchased a new stake in shares of Astera Labs in the fourth quarter valued at $25,000. Trifecta Capital Advisors LLC purchased a new stake in shares of Astera Labs in the second quarter valued at $79,000. CX Institutional boosted its stake in shares of Astera Labs by 1,330.8% during the second quarter. CX Institutional now owns 186 shares of the company’s stock valued at $90,000 after acquiring an additional 173 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its stake in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Down 0.4%

ALAB opened at $320.17 on Tuesday. The firm has a market capitalization of $55.55 billion, a P/E ratio of 158.50 and a beta of 3.84. The firm’s 50 day moving average is $357.48 and its 200-day moving average is $241.79. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total transaction of $3,276,963.90. Following the sale, the director directly owned 5,292 shares of the company’s stock, valued at approximately $1,928,140.20. The trade was a 62.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 631,979 shares of company stock worth $215,479,247. 10.40% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have recently commented on ALAB shares. Jefferies Financial Group upped their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Roth Capital restated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Evercore reaffirmed an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Needham & Company LLC increased their target price on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, Susquehanna lifted their price target on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.